Filtros de búsqueda

Lista de obras de

A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies

artículo científico publicado en 2017

A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation

artículo científico publicado en 2009

Brain miffed by macrophage migration inhibitory factor

artículo científico

Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia

artículo científico publicado en 2015

Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis

artículo científico publicado en 2011

Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions

artículo científico publicado en 2015

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor

artículo científico publicado en 2012

Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression

artículo científico publicado en 2012

MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models

artículo científico publicado en 2007

MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease

artículo científico publicado en 2009

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

artículo científico publicado en 2007

Macrophage migration inhibitory factor and its role in autoimmune diseases

artículo científico publicado en 2004

Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle

artículo científico publicado en 2007

Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE.

artículo científico publicado en 2015

Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis

artículo científico publicado en 2013

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

artículo científico publicado en 2016

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

artículo científico publicado en 2015

Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity

artículo científico publicado en 2005

Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation

artículo científico publicado en 2013

The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice

artículo científico publicado en 2012

The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda